
According to the FDA, non-prescription pain relievers such as aspirin, ibuprofen and acetaminophen need stronger health warnings regarding risks of liver and stomach problems.
This will affect brands such as Motrin, Advil, Aleve and Tylenol.
Some manufacturers already note the health risks on packages, but the FDA wants the warnings to be more prominent and more specific.
The FDA has suggested that products with acetaminophen should include warnings for liver toxicity, and over-the-counter NSAIDs should include warnings for stomach bleeding as a side effect in a variety of scenarios (patients over age 60 or those who have had ulcers).
About 100 people die in the U.S. each year after unintentionally overdosing on acetaminophen.